Global /China /Healthcare /Drug Manufacturers - General /688073

Bide Pharmatech Co., Ltd.

688073

• SSE: 688073 • Delayed

63.52CNY 6.3%

9.39 USD

As of 14 June 2026, Bide Pharmatech Co., Ltd. has a market cap of $759.43M USD, ranking #12396 globally and #3687 in China. It ranks #1135 in the Healthcare sector, and #420 in the Drug Manufacturers - General industry.

Global Rank

12396

Country Rank

3687

Sector Rank

1135

Industry Rank

420

Key Stats

Market Cap

$759.43MUSD

5.15B CNY

Enterprise Value

$627.34MUSD

4.25B CNY

Revenue (TTM)

$195.37MUSD

1.32B CNY

EBITDA (TTM)

$37.85MUSD

256.13M CNY

Net Income (TTM)

$22.39MUSD

151.74M CNY

EBITDA Margin

19%

Profit Margin

11%

PE Ratio

34.5

Forward PE

25.3

PS Ratio

3.9

PB Ratio

2.5

EV/EBITDA

16.4

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Lan Dai open_in_new

Employees

129

Founded

2007

Website

bidepharmatech.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
6.3%	10%	15%	-3.5%	-21%	4%	55%	-32%	-11%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688073 上海毕得医药科技股份有限公司 Class A ISIN: CNE100005NV3 Shares Out.: Shares Outstanding: 37.825M¹ Shares Float: 11.928M² TV: TradingView: SSE: 688073 SA: Stock Analysis: SHA: 688073 YF: Yahoo Finance: 688073.SS GF: Google Finance: SHA: 688073 BA: Barron's: 688073 MS: Morningstar: XSHG: 688073	63.52 CNY	TV: TradingView: SSE: 688073 SA: Stock Analysis: SHA: 688073 YF: Yahoo Finance: 688073.SS GF: Google Finance: SHA: 688073 BA: Barron's: 688073 MS: Morningstar: XSHG: 688073

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Bide Pharmatech Co., Ltd.

Bide Pharmatech Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. Its products are used in life sciences, organic chemistry, analytical chemistry, and other applications. The company was founded in 2007 and is based in Shanghai, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 7K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 6K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 4K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 100K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 72K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 47K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 42K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 38K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 36K%	20.5	Switzerland

chevron_leftBack